Pharmafile Logo
Pharmafocus logo
Advanced Search

Pharma welcomes Hunt to top health job

September 5, 2012
Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …

News

Pfizer to develop phase II cancer vaccine

September 4, 2012
Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …

News

Valeant to buy dermatogy firm Medicis

September 4, 2012
Sales and Marketing Valeant

Speciality pharma company Valeant is to acquire dermatology-focused Medicis for $2.6 billion.Medicis’ portfolio includes ‘cosmaceutical’ prescription brands such as Solodyn, …

News

Contract research news in brief

September 4, 2012
Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …

News

Genzyme recalls drug on failed stability testing

September 4, 2012
Manufacturing and Production Genzyme, Stability Testing, pharma recalls

Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there …

News

Cash incentive for NHS digital info sharing

September 3, 2012
NHS, digital

NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …

News

Cash incentive for NHS digital info sharing

September 3, 2012
NHS, digital

NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …

News
Novartis

Novartis cheered by COPD trial results

September 3, 2012
Research and Development COPD, ERS, Novartis

One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …

News
db3

The ex-CEO’s Job Blog – part 1

September 3, 2012
Medical Communications David Barratt, Jobs, careers, pharma jobs, restructuring, the ex-CEO's job blog

I have seen a lot in my healthcare career. Been round the block more than twice, as they say. I …

Feature

New quad HIV pill passed by FDA

September 2, 2012
Sales and Marketing FDA, Gilead, HIV, stribild

Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …

News

J&J buys into Genmab cancer drug

August 31, 2012
Sales and Marketing Cancer, Genmab, Janssen Cilag, Janssen-Cilag, Johnson & Johnson, multiple myeloma

Danish biotech company Genmab has sold the worldwide rights for one of its cancer drugs to Johnson & Johnson-owned Janssen …

News
GSK Stevenage

ABPI worried by public ignorance about medicines

August 31, 2012
Sales and Marketing ABPI, UK

People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …

News

Publicis creates new digital agency Razorfish Healthware

August 31, 2012
Medical Communications Razorfish Healthware, advertising, digital, publicis

 Two Publicis agencies, Razorfish Health and Publicis Healthware International are to be merged to create Razorfish Healthware, which will focus …

News

CPC Healthcare joins Indigenus network

August 31, 2012
Medical Communications CPC Healthcare Communications, CementBloc, Indegenus, Indigenus

CPC Healthcare Communications, based in Toronto, Canada, has joined Indigenus, the global network of independent healthcare agencies.The Indigenus network spans …

News

Patient death halts BMS hep C trial

August 30, 2012
Sales and Marketing BMS, HCV, hepatitis C

Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …

News

Genzyme ‘confident’ of FDA nod for MS drug

August 29, 2012
Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis

Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …

News

Efient fails to prove superiority to Plavix

August 29, 2012
Brillinta, Efient, Plavix, prasugrel, ticagrelor

Daiichi Sankyo and Lilly’s heart drug Efient has failed to come up to the mark in a late-stage trial which …

News

Innovation scorecard gets ABPI thumbs-up

August 29, 2012
Sales and Marketing NHS, NICE, market access

 An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …

News
Pascal Soirot takes over in October

AstraZeneca poaches Soirot from Roche to be new chief executive

August 28, 2012
Sales and Marketing AstraZeneca, Soirot

AstraZeneca has poached Roche’s head of pharma, Pascal Soriot, to be its new chief executive. He joins on 1 October. …

News

Novartis’ myelofibrosis treatment approved in Europe

August 28, 2012
Sales and Marketing Incyte, Jakavi, Novartis, Orphan Drugs, myelofibrosis

Novartis’ Jakavi, a new treatment for patients with myelofibrosis has been approved in Europe. The drug was co-developed with Incyte, …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026